Dr. Jia Ruan on Mantle Cell Lymphoma Treatment Challenges

Video

Jia Ruan, MD, PhD, an associate professor at Weill Cornell Medical College, talks about initial treatment methods for mantle cell lymphoma (MCL).

Jia Ruan, MD, PhD, an associate professor at Weill Cornell Medical College, talks about initial treatment methods for mantle cell lymphoma (MCL).

Because MCL is not common, it is often difficult to determine the best initial treatment, says Ruan. The majority of previous studies have focused on combination chemotherapy treatments, which do not always cure MCL and can often be too toxic for the many MCL patients who are elderly.

A recent phase II study, explored the combination of rituximab and lenalidomide to determine if the regimen was both non-toxic and effective for the treatment of MCL.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD